Works matching IS 08876924 AND DT 2013 AND VI 27 AND IP 11

Results: 28

NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model.

Published in:

2013

By:

Mallardo, M;
Caronno, A;
Pruneri, G;
Raviele, P R;
Viale, A;
Pelicci, P G;
Colombo, E

Publication type:

Journal Article

A role for reactive oxygen species in JAK2(V617F) myeloproliferative neoplasm progression.

Published in:

2013

By:

Marty, C;
Lacout, C;
Droin, N;
Le Couédic, J-P;
Ribrag, V;
Solary, E;
Vainchenker, W;
Villeval, J-L;
Plo, I

Publication type:

Journal Article

Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2149, doi. 10.1038/leu.2013.109

By:

Fernandez, C;
Santos-Silva, M C;
López, A;
Matarraz, S;
Jara-Acevedo, M;
Ciudad, J;
Gutierrez, M L;
Sánchez, M L;
Salvador-Osuna, C;
Berruezo, M J;
Díaz-Arias, J Á;
Palomo-Hernández, A M;
Colado, E;
González, N;
Gallardo, D;
Asensio, A;
García-Sánchez, R;
Saldaña, R;
Cerveró, C;
Carboné-Bañeres, A

Publication type:

Article

Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2253, doi. 10.1038/leu.2013.123

By:

Nieborowska-Skorska, M;
Hoser, G;
Hochhaus, A;
Stoklosa, T;
Skorski, T

Publication type:

Article

Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2268, doi. 10.1038/leu.2013.230

By:

Hörl, S;
Bánki, Z;
Huber, G;
Ejaz, A;
Windisch, D;
Muellauer, B;
Willenbacher, E;
Steurer, M;
Stoiber, H

Publication type:

Article

Highly variable clinical manifestations in a large family with a novel GATA2 mutation.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2247, doi. 10.1038/leu.2013.105

By:

Mutsaers, P G N J;
van de Loosdrecht, A A;
Tawana, K;
Bödör, C;
Fitzgibbon, J;
Menko, F H

Publication type:

Article

Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2129, doi. 10.1038/leu.2013.107

By:

Scotland, S;
Saland, E;
Skuli, N;
de Toni, F;
Boutzen, H;
Micklow, E;
Sénégas, I;
Peyraud, R;
Peyriga, L;
Théodoro, F;
Dumon, E;
Martineau, Y;
Danet-Desnoyers, G;
Bono, F;
Rocher, C;
Levade, T;
Manenti, S;
Junot, C;
Portais, J-C;
Alet, N

Publication type:

Article

STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2244, doi. 10.1038/leu.2013.104

By:

Ohgami, R S;
Ma, L;
Merker, J D;
Martinez, B;
Zehnder, J L;
Arber, D A

Publication type:

Article

Cutaneous T cell lymphoma cells are targets for immune checkpoint ligand PD-L1-specific, cytotoxic T cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2251, doi. 10.1038/leu.2013.118

By:

Munir, S;
Andersen, G H;
Woetmann, A;
Ødum, N;
Becker, J C;
Andersen, M H

Publication type:

Article

The MLL recombinome of acute leukemias in 2013.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2165, doi. 10.1038/leu.2013.135

By:

Meyer, C;
Hofmann, J;
Burmeister, T;
Gröger, D;
Park, T S;
Emerenciano, M;
Pombo de Oliveira, M;
Renneville, A;
Villarese, P;
Macintyre, E;
Cavé, H;
Clappier, E;
Mass-Malo, K;
Zuna, J;
Trka, J;
De Braekeleer, E;
De Braekeleer, M;
Oh, S H;
Tsaur, G;
Fechina, L

Publication type:

Article

Effect of graft source on mismatched unrelated donor hemopoietic stem cell transplantation after reduced intensity conditioning.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2113, doi. 10.1038/leu.2013.170

By:

Malard, F;
Fürst, S;
Loirat, M;
Chevallier, P;
El-Cheikh, J;
Guillaume, T;
Delaunay, J;
Le Gouill, S;
Moreau, P;
Blaise, D;
Mohty, M

Publication type:

Article

NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2248, doi. 10.1038/leu.2013.114

By:

Mallardo, M;
Caronno, A;
Pruneri, G;
Raviele, P R;
Viale, A;
Pelicci, P G;
Colombo, E

Publication type:

Article

Early morbidity and mortality in childhood acute lymphoblastic leukemia with very high white blood cell count.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2259, doi. 10.1038/leu.2013.137

By:

Vaitkeviciene, G;
Heyman, M;
Jonsson, O G;
Lausen, B;
Harila-Saari, A;
Stenmarker, M;
Taskinen, M;
Zvirblis, T;
Åsberg, A;
Groth-Pedersen, L;
Rageliene, L;
Schmiegelow, K

Publication type:

Article

Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2256, doi. 10.1038/leu.2013.136

By:

Enshaei, A;
Schwab, C J;
Konn, Z J;
Mitchell, C D;
Kinsey, S E;
Wade, R;
Vora, A;
Harrison, C J;
Moorman, A V

Publication type:

Article

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2196, doi. 10.1038/leu.2013.98

By:

Strefford, J C;
Sutton, L-A;
Baliakas, P;
Agathangelidis, A;
Malčíková, J;
Plevova, K;
Scarfó, L;
Davis, Z;
Stalika, E;
Cortese, D;
Cahill, N;
Pedersen, L B;
di Celle, P F;
Tzenou, T;
Geisler, C;
Panagiotidis, P;
Langerak, A W;
Chiorazzi, N;
Pospisilova, S;
Oscier, D

Publication type:

Article

Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2157, doi. 10.1038/leu.2013.111

By:

Nomdedéu, J F;
Hoyos, M;
Carricondo, M;
Bussaglia, E;
Estivill, C;
Esteve, J;
Tormo, M;
Duarte, R;
Salamero, O;
de Llano, M P Q;
García, A;
Bargay, J;
Heras, I;
Martí-Tutusaus, J M;
Llorente, A;
Ribera, J M;
Gallardo, D;
Aventin, A;
Brunet, S;
Sierra, J

Publication type:

Article

Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2242, doi. 10.1038/leu.2013.101

By:

Leleu, X;
Fouquet, G;
Hebraud, B;
Roussel, M;
Caillot, D;
Chrétien, M L;
Arnulf, B;
Szalat, R;
Garderet, L;
Benajiba, L;
Pegourie, B;
Regny, C;
Royer, B;
Caulier, A;
Stoppa, A M;
Garciaz, S;
Touzeau, C;
Chaleteix, C;
Fermand, J P;
Loiseau, H A

Publication type:

Article

Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2254, doi. 10.1038/leu.2013.129

By:

Metzgeroth, G;
Schwaab, J;
Gosenca, D;
Fabarius, A;
Haferlach, C;
Hochhaus, A;
Cross, N C P;
Hofmann, W-K;
Reiter, A

Publication type:

Article

p190-B RhoGAP regulates the functional composition of the mesenchymal microenvironment.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2209, doi. 10.1038/leu.2013.103

By:

Raman, R;
Kumar, R S;
Hinge, A;
Kumar, S;
Nayak, R;
Xu, J;
Szczur, K;
Cancelas, J A;
Filippi, M-D

Publication type:

Article

Targeting oncogene expression to endothelial cells induces proliferation of the myelo-erythroid lineage by repressing the notch pathway.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2229, doi. 10.1038/leu.2013.132

By:

Alghisi, E;
Distel, M;
Malagola, M;
Anelli, V;
Santoriello, C;
Herwig, L;
Krudewig, A;
Henkel, C V;
Russo, D;
Mione, M C

Publication type:

Article

Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2177, doi. 10.1038/leu.2013.91

By:

Wei, Y;
Chen, R;
Dimicoli, S;
Bueso-Ramos, C;
Neuberg, D;
Pierce, S;
Wang, H;
Yang, H;
Jia, Y;
Zheng, H;
Fang, Z;
Nguyen, M;
Ganan-Gomez, I;
Ebert, B;
Levine, R;
Kantarjian, H;
Garcia-Manero, G

Publication type:

Article

Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2200, doi. 10.1038/leu.2013.169

By:

Hörl, S;
Bánki, Z;
Huber, G;
Ejaz, A;
Windisch, D;
Muellauer, B;
Willenbacher, E;
Steurer, M;
Stoiber, H

Publication type:

Article

The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2220, doi. 10.1038/leu.2013.54

By:

Garnier, N;
Petruccelli, L A;
Molina, M F;
Kourelis, M;
Kwan, S;
Diaz, Z;
Schipper, H M;
Gupta, A;
del Rincon, S V;
Mann, K K;
Miller, W H

Publication type:

Article

Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2262, doi. 10.1038/leu.2013.138

By:

Soderquist, R;
Bates, D J P;
Danilov, A V;
Eastman, A

Publication type:

Article

SYK regulates mTOR signaling in AML.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2118, doi. 10.1038/leu.2013.89

By:

Carnevale, J;
Ross, L;
Puissant, A;
Banerji, V;
Stone, R M;
DeAngelo, D J;
Ross, K N;
Stegmaier, K

Publication type:

Article

F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2139, doi. 10.1038/leu.2013.108

By:

Kruczynski, A;
Pillon, A;
Créancier, L;
Vandenberghe, I;
Gomes, B;
Brel, V;
Fournier, E;
Annereau, J-P;
Currie, E;
Guminski, Y;
Bonnet, D;
Bailly, C;
Guilbaud, N

Publication type:

Article

Genetic characterization of SF3B1 mutations in single chronic lymphocytic leukemia cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2264, doi. 10.1038/leu.2013.155

By:

Wu, X;
Tschumper, R C;
Jelinek, D F

Publication type:

Article

A role for reactive oxygen species in JAK2<sup>V617F</sup> myeloproliferative neoplasm progression.

Published in:

Leukemia (08876924), 2013, v. 27, n. 11, p. 2187, doi. 10.1038/leu.2013.102

By:

Marty, C;
Lacout, C;
Droin, N;
Le Couédic, J-P;
Ribrag, V;
Solary, E;
Vainchenker, W;
Villeval, J-L;
Plo, I

Publication type:

Article